2023 Q2 Form 10-Q Financial Statement

#000110465923059855 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.125M $1.204M
YoY Change -22.14% -28.75%
% of Gross Profit
Research & Development $6.313M $5.706M
YoY Change 46.59% 25.14%
% of Gross Profit
Depreciation & Amortization $18.75K $16.95K
YoY Change 26.08% 47.86%
% of Gross Profit
Operating Expenses $6.920M $8.045M
YoY Change 7.6% 28.5%
Operating Profit -$11.92M -$8.045M
YoY Change 86.64% 28.5%
Interest Expense $161.7K $163.5K
YoY Change 24.84% 925.78%
% of Operating Profit
Other Income/Expense, Net $4.247M $3.445M
YoY Change 3180.22% 21515.02%
Pretax Income -$7.673M -$4.600M
YoY Change 22.62% -26.34%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$7.673M -$4.600M
YoY Change 22.62% -26.34%
Net Earnings / Revenue
Basic Earnings Per Share $0.12 $0.07
Diluted Earnings Per Share $0.12 $0.07
COMMON SHARES
Basic Shares Outstanding 63.17M 63.01M
Diluted Shares Outstanding 63.16M 63.02M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.10M $18.56M
YoY Change -60.93% -54.92%
Cash & Equivalents $14.11M $18.56M
Short-Term Investments
Other Short-Term Assets $900.0K $696.8K
YoY Change -1.62% -27.27%
Inventory
Prepaid Expenses $936.1K $696.8K
Receivables $3.188M $1.361M
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.23M $20.62M
YoY Change -50.8% -51.13%
LONG-TERM ASSETS
Property, Plant & Equipment $414.0K $278.0K
YoY Change 74.65% 80.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.000M $3.000M
YoY Change 0.0% 0.0%
Total Long-Term Assets $76.01M $75.84M
YoY Change 0.6% 0.5%
TOTAL ASSETS
Total Short-Term Assets $18.23M $20.62M
Total Long-Term Assets $76.01M $75.84M
Total Assets $94.24M $96.46M
YoY Change -16.31% -18.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.900M $2.720M
YoY Change 110.79% 33.86%
Accrued Expenses $100.0K $43.81K
YoY Change 2.11% -45.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.88M $13.46M
YoY Change 68.86% 121.51%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.100M $886.2K
YoY Change 34.75% -84.01%
Total Long-Term Liabilities $5.100M $886.2K
YoY Change 34.75% -84.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.88M $13.46M
Total Long-Term Liabilities $5.100M $886.2K
Total Liabilities $18.98M $14.35M
YoY Change 58.06% 23.47%
SHAREHOLDERS EQUITY
Retained Earnings -$574.2M -$566.5M
YoY Change 5.22% 5.02%
Common Stock $616.2M $616.1M
YoY Change 0.12% 0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.26M $82.11M
YoY Change
Total Liabilities & Shareholders Equity $94.24M $96.46M
YoY Change -16.31% -18.01%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$7.673M -$4.600M
YoY Change 22.62% -26.34%
Depreciation, Depletion And Amortization $18.75K $16.95K
YoY Change 26.08% 47.86%
Cash From Operating Activities -$4.368M -$4.148M
YoY Change -13.09% -37.95%
INVESTING ACTIVITIES
Capital Expenditures $154.7K
YoY Change -257.68%
Acquisitions
YoY Change
Other Investing Activities $25.00K $0.00
YoY Change -44.15%
Cash From Investing Activities -$129.7K $0.00
YoY Change 143.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 41.52K 40.67K
YoY Change
NET CHANGE
Cash From Operating Activities -4.368M -4.148M
Cash From Investing Activities -129.7K 0.000
Cash From Financing Activities 41.52K 40.67K
Net Change In Cash -4.456M -4.107M
YoY Change -12.27% -38.55%
FREE CASH FLOW
Cash From Operating Activities -$4.368M -$4.148M
Capital Expenditures $154.7K
Free Cash Flow -$4.523M
YoY Change -8.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63018308
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62972155
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001526243
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39918
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Perpetua Resources Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
405 S. 8th Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 201
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boise
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83702
CY2023Q1 dei City Area Code
CityAreaCode
208
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
901-3060
CY2023Q1 dei Security12b Title
Security12bTitle
Common Shares, without par value
CY2023Q1 dei Trading Symbol
TradingSymbol
PPTA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
63165367
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18559712
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22667047
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1360978
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
280150
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
696844
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
614930
CY2023Q1 us-gaap Assets Current
AssetsCurrent
20617534
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23562127
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
278026
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
294980
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42482
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68675
CY2023Q1 ppta Mine Reclamation Asset Bond
MineReclamationAssetBond
3000000
CY2022Q4 ppta Mine Reclamation Asset Bond
MineReclamationAssetBond
3000000
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
72519373
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
72519373
CY2023Q1 us-gaap Assets
Assets
96457415
CY2022Q4 us-gaap Assets
Assets
99445155
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2720126
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2741516
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43812
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70449
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
10695372
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
9590766
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13459310
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12402731
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1732
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
886177
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
1210170
CY2023Q1 us-gaap Liabilities
Liabilities
14345487
CY2022Q4 us-gaap Liabilities
Liabilities
13614633
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63139533
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63011777
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
616068044
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
615553448
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32570761
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32203858
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-566526877
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-561926784
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82111928
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
85830522
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96457415
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
99445155
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
390983
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
303411
CY2023Q1 us-gaap Depreciation
Depreciation
16954
CY2022Q1 us-gaap Depreciation
Depreciation
11466
CY2023Q1 us-gaap Officers Compensation
OfficersCompensation
221262
CY2022Q1 us-gaap Officers Compensation
OfficersCompensation
262948
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
5706425
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
4560053
CY2023Q1 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1118303
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
162488
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
218573
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
277483
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
745409
CY2023Q1 ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
151413
CY2022Q1 ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
158973
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8045311
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6260833
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-688
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-30751
CY2023Q1 ppta Government Grant Income
GovernmentGrantIncome
3281711
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
162463
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
31442
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3445218
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15939
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4600093
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6244894
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63018308
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62972155
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
111600595
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
676249
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6244894
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
106031950
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
85830522
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
840827
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40672
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4600093
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82111928
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4600093
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-6244894
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
840827
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
676249
CY2023Q1 us-gaap Depreciation
Depreciation
16954
CY2022Q1 us-gaap Depreciation
Depreciation
11466
CY2023Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
1732
CY2022Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
15248
CY2023Q1 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1118303
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
131
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
555
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1080828
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-206251
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
81914
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
11867
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-21833
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-806176
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
337690
CY2022Q1 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
499903
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4148137
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6684677
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
40672
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40672
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
130
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
555
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4107335
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6684122
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22667047
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47852846
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18559712
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41168724
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
78790
CY2023Q1 us-gaap Cash
Cash
5126811
CY2022Q1 us-gaap Cash
Cash
5734237
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
9225915
CY2022Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
20248248
CY2023Q1 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
4206986
CY2022Q1 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
15186239
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18559712
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41168724
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>Nature of Operations and Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">Perpetua Resources Corp. (the “Corporation”, the “Company”, “Perpetua Resources” or “Perpetua”) was incorporated on February 22, 2011 under the <i style="font-style:italic;">Business Corporation Act</i> (British Columbia). The Company was organized to hold shares in wholly owned subsidiaries that locate, acquire, develop and restore mineral properties located principally in the Stibnite – Yellow Pine mining district in Valley County, Idaho, USA. The Company’s principal asset is 100% ownership in subsidiaries that control the Stibnite Gold Project (“Stibnite Gold Project” or the “Project”). The Company currently operates in one segment, mineral exploration in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of Perpetua Resources Corp. and its wholly owned subsidiaries, Perpetua Resources Idaho, Inc. and Idaho Gold Resource Company, LLC. Intercompany transactions and balances have been eliminated. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The unaudited condensed consolidated financial statements do not include all disclosures required of annual consolidated financial statements and, accordingly, should be read in conjunction with our annual financial statements for the year ended December 31, 2022. Operating results for the three months ended March 31, 2023 may not be indicative of results expected for the full year ending December 31, 2023. Management estimates that the Company’s 2023 effective tax rate will be 0% due to the Company’s cumulative loss position, historical net operating losses (“NOLs”), and other available evidence related to the Company’s ability to generate taxable income. Accordingly, there is no income tax provision or benefit for the three month period ended March 31, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the results for the interim periods reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The Company’s latest liquidity forecast indicates that available cash resources and other sources of liquidity are expected to be exhausted in the first quarter of 2024 due to increases to anticipated costs for the Company’s Administrative Settlement and Order on Consent (“ASAOC”) obligations in 2023. See Note 5 for more information. Although the Company’s current capital resources and liquidity include up to $24.8 million in funding awarded in December 2022 under the TIA pursuant to Title III of the DPA, such funding is available only for the specified costs related to permitting, early restoration activities and advancing construction readiness and is not available to fund the Company’s costs pursuant to its ASAOC obligations and certain corporate expenses. Absent additional financing, the Company would no longer be able to meet its ongoing obligations or progress critical permitting efforts. The Company continues to explore various funding opportunities, which may include the issuance of additional equity, new debt, or project specific debt; government funding; and/or other financing opportunities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">Due to increasing costs of the ASAOC restoration obligations resulting in part from rising inflation, and other corporate expenses, we do not expect the Company will have sufficient available resources to discharge its liabilities as they become due or progress critical permitting efforts for at least 12 months from the date hereof. On May 12, 2023, the Company entered into a Controlled Equity Offering<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">SM</sup> Sales Agreement with Cantor Fitzgerald &amp; Co. as sales agent (the “Agent”) for an at-the-market program for the sale from time to time of the Company’s common stock having an aggregate offering price of up to $20,000,000. Sales under the program are subject to certain conditions, including market conditions, and there is no assurance that the Company will be able to raise funds under the program, at acceptable share prices or at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">We believe our plans outlined above to obtain sufficient funding will be successful although there is no certainty that these plans will result in needed liquidity for a reasonable period of time. However, our expectation of incurring significant ASAOC and other costs in the foreseeable future that are not eligible for DPA funding reimbursement and the need for additional funding to further support the development of our planned operations, raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited condensed consolidated financial statements are issued. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">These financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business and do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 36pt;"><i style="font-style:italic;">Loss per share</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">Basic loss per share is computed by dividing the net loss by the weighted average number of shares outstanding during the reporting period. Diluted loss per share is computed similar to basic loss per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of share purchase options and warrants, if dilutive. The Company’s potential dilutive shares of common stock include outstanding share purchase options, restricted share units, performance share units, deferred share units and warrants. Potentially dilutive shares as of March 31, 2023 and 2022, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">March 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share purchase options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,778,250</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,068,650</p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,374,218</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 725,675</p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 200,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 200,000</p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,352,468</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,994,325</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">All potentially dilutive shares were excluded from the calculation of diluted loss per share as their exercise and conversion would be anti-dilutive.</p>
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 ppta Funding Awarded Under Technology Investment Agreement
FundingAwardedUnderTechnologyInvestmentAgreement
24800000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3352468
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2994325
CY2022Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
5424450
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
11581549
CY2022Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
9388297
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
7500000
CY2021Q1 ppta Payment Of Cash Collateral
PaymentOfCashCollateral
3000000.0
CY2022Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
3963847
CY2023Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
72519373
CY2022Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
72519373
CY2023Q1 ppta Percentage Of Net Smelter Returns Royalty
PercentageOfNetSmelterReturnsRoyalty
0.017
CY2023Q1 ppta Annual Payments Due Under Option Agreements
AnnualPaymentsDueUnderOptionAgreements
180000
CY2023Q1 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
840827
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
676249
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1300000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1300000
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
886177
CY2023Q1 ppta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Scheduled To Vest In Remainder Of Fiscal Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedScheduledToVestInRemainderOfFiscalYear
7500
CY2023Q1 ppta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Scheduled To Vest In Year Two Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedScheduledToVestInYearTwoNumber
247524
CY2023Q1 ppta Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Scheduled To Vest In Year Three Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedScheduledToVestInYearThreeNumber
276908
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
531932
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
200000
CY2021Q1 us-gaap Environmental Costs Recognized Capitalized
EnvironmentalCostsRecognizedCapitalized
7473805
CY2021Q1 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
7473805
CY2022Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
10800936
CY2021Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
9888200
CY2023Q1 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1118303
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
337690
CY2022Q1 us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
499903
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
11581549
CY2022Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
9388297
CY2023Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
10695372
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
0
CY2022Q1 ppta Government Grant Income
GovernmentGrantIncome
0
CY2023Q1 ppta Government Assistance Current Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
true
CY2023Q1 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
1172050
CY2022Q4 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
50000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001104659-23-059855-index-headers.html Edgar Link pending
0001104659-23-059855-index.html Edgar Link pending
0001104659-23-059855.txt Edgar Link pending
0001104659-23-059855-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ppta-20230331.xsd Edgar Link pending
ppta-20230331x10q.htm Edgar Link pending
ppta-20230331x10q004.jpg Edgar Link pending
ppta-20230331xex1d1.htm Edgar Link pending
ppta-20230331xex31d1.htm Edgar Link pending
ppta-20230331xex31d2.htm Edgar Link pending
ppta-20230331xex32d1.htm Edgar Link pending
ppta-20230331xex32d2.htm Edgar Link pending
ppta-20230331xex5d1.htm Edgar Link pending
ppta-20230331xex5d1001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
ppta-20230331_cal.xml Edgar Link unprocessable
ppta-20230331_def.xml Edgar Link unprocessable
ppta-20230331_lab.xml Edgar Link unprocessable
ppta-20230331_pre.xml Edgar Link unprocessable
ppta-20230331x10q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending